Clinical Trial Update: A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study of a recombinant Staphylococcus aureus vaccine (produced in Escherichia coli) in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• Recombinant Staphylococcus aureus vaccine (Escherichia coli) (Staphylococcus aureus vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Staphylococcus Aureus Infection | EARLY_Phase 1 | Status: COMPLETED